GC Therapeutics Analysis: $75M Raised
What is GC Therapeutics?
Plug-and-play iPSC cellular programming platform
Location
Cambridge, United States
Employees
11-50
Founded
2019
Product Features & Capabilities
- TFome platform for iPSC cellular programming
- Scalable cell therapy development
- Off-the-shelf iPSC-based medicines
Use Cases
Develop cell therapies for gastrointestinal diseases; Create therapies for neurological conditions; Advance treatments for immunological diseases; Scale production of iPSC-based medicines; Improve patient access to advanced therapies
Other Considerations
Founded by George Church, Ph.D.; Backed by a team of experienced scientists; Focused on addressing healthcare burdens through advanced therapies
See something that needs updating? Suggest edits to this profile.